{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:27:09Z","timestamp":1793950029171,"version":"4.8.0"},"reference-count":46,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anxiety and other non-motor symptoms can greatly diminish quality of life in people with Parkinson's Disease (PD). Yet, few randomized controlled trials (RCTs) have assessed accessible, non-pharmacological mental health treatments for people with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the feasibility and impact of brief, remotely-delivered meditation and breathwork on neuropsychiatric symptoms in people with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this 18-week RCT, intervention participants attended weekly webinars for six weeks, while waitlisted controls maintained their usual routine before crossing over at six weeks. Participants were assessed for weekly compliance trends (primary outcome) and changes in anxiety (primary outcome), depression, perceived stress, and other non-motor symptoms at 6-week intervals: baseline and weeks 6 (T2), 12 (T3), and 18 (T4). Weekly compliance was collected in each group for 12 weeks. Anxiety was measured using the Parkinson's Anxiety Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was a significant decrease in the primary outcome, anxiety, in the intervention group (n\u2009=\u200917) compared to the waitlist control (n\u2009=\u200921) after 6 weeks of meditation and breathwork practice (mean difference (MD)= \u22125.0, 95% CI [\u22129.5, \u22120.49],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.03). Within-group analysis further confirmed a significant reduction in anxiety (MD\u2009=\u2009\u22124.7, 95% CI [2.10,7.33],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001) in the intervention group (n\u2009=\u200928). Thirty-one percent of participants met the compliance definition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Remotely-delivered meditation and breathwork through the BSM program significantly reduced anxiety in individuals with PD in our study and may be a promising non-pharmacological therapy. A larger RCT with continuous wellness coaching is warranted to more rigorously assess efficacy and optimize protocols.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Clinical trial registration:<\/jats:bold>\n                      ClinicalTrials.gov, NCT05335850,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT05335850\">https:\/\/clinicaltrials.gov\/study\/NCT05335850<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x261463924","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:35:37Z","timestamp":1786084537000},"page":"1584-1597","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Meditation and breathwork on anxiety in Parkinson's disease: A pilot randomized controlled trial"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9265-077X","authenticated-orcid":false,"given":"Akila","family":"Rayapuraju","sequence":"first","affiliation":[{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-8158","authenticated-orcid":false,"given":"Preeti U","family":"Reed","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-0696","authenticated-orcid":false,"given":"Jennifer","family":"Liu","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA, USA"},{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4022-7014","authenticated-orcid":false,"given":"Morgan","family":"Pratt","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulsi","family":"Chase","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Novack","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-7168","authenticated-orcid":false,"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[{"name":"University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4793-0574","authenticated-orcid":false,"given":"David K","family":"Simon","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA, USA"},{"name":"Beth Israel Deaconess Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-3885","authenticated-orcid":false,"given":"Balachundhar","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30299-5"},{"key":"e_1_3_3_3_2","unstructured":"Parkinson\u2019s disease - Level 3 cause | Institute for Health Metrics and Evaluation https:\/\/www.healthdata.org\/research-analysis\/diseases-injuries-risks\/factsheets\/2021-parkinsons-disease-level-3-disease (accessed 21 April 2025)."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70373-8"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2019.03.002"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26643"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-019-0102-8"},{"key":"e_1_3_3_8_2","unstructured":"Anxiety | Parkinson\u2019s Foundation https:\/\/www.parkinson.org\/understanding-parkinsons\/non-movement-symptoms\/anxiety (accessed 21 April 2025)."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2009.21.4.413"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715002196"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1309989"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123248"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70144"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/08919887241254471"},{"key":"e_1_3_3_15_2","first-page":"100126","article-title":"Change in the Parkinson anxiety scale correlates with change in other clinical measures of anxiety over time","volume":"6","author":"Schneider RB","year":"2021","unstructured":"Schneider RB, Auinger P, Tarolli CG, et al. Change in the Parkinson anxiety scale correlates with change in other clinical measures of anxiety over time. Clin Park Relat Disord 2021; 6: 100126.","journal-title":"Clin Park Relat Disord"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000336340.89821.b3"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182516244"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1363115"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPRLS.S83165"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212735"},{"key":"e_1_3_3_21_2","first-page":"1","article-title":"The experience of anxiety for people with Parkinson\u2019s disease","volume":"9","author":"Blundell EK","year":"2023","unstructured":"Blundell EK, Grover LE, Stott J, et al. The experience of anxiety for people with Parkinson\u2019s disease. Npj Park Dis 2023; 9: 1\u20139.","journal-title":"Npj Park Dis"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/aphw.12341"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/jora.12971"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.635816"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.944973"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15839"},{"key":"e_1_3_3_27_2","first-page":"570","article-title":"The effects of mindfulness-based interventions in people with Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"78","author":"Yi M","year":"2024","unstructured":"Yi M, Zhang W, Zhao B, et al. The effects of mindfulness-based interventions in people with Parkinson\u2019s disease: a systematic review and meta-analysis. Clin Gerontol 2024; 78: 570\u2013588. DOI: https:\/\/doi.org\/10.1080\/07317115.2024.2314192","journal-title":"Clin Gerontol"},{"key":"e_1_3_3_28_2","first-page":"101","article-title":"Effects of meditation and yoga on anxiety, depression and chronic inflammation in patients with Parkinson\u2019s disease: a randomized clinical trial","volume":"94","author":"Kwok JYY","year":"2025","unstructured":"Kwok JYY, Chan LML, Lai CA, et al. Effects of meditation and yoga on anxiety, depression and chronic inflammation in patients with Parkinson\u2019s disease: a randomized clinical trial. Psychother Psychosom 2025; 94: 101\u2013118.","journal-title":"Psychother Psychosom"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25919"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.2307\/2136404"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18446.1"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/aphw.12341"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.635816"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2016.03.009"},{"key":"e_1_3_3_37_2","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen J","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. L. Erlbaum Associates, 1988.","edition":"2"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/07317115.2022.2074814"},{"key":"e_1_3_3_39_2","first-page":"5","article-title":"Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression","volume":"62","author":"Nierenberg AA","year":"2001","unstructured":"Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001; 62: 5.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610215000885"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-021-01272-6"},{"key":"e_1_3_3_42_2","article-title":"Adherence to non-pharmacological interventions in Parkinson\u2019s disease: a rapid evidence assessment of the literature","volume":"14","author":"Li J","year":"2024","unstructured":"Li J, Aulakh N, Culum I, et al. Adherence to non-pharmacological interventions in Parkinson\u2019s disease: a rapid evidence assessment of the literature. J Park Dis 2024; 14: S35\u2013S52.","journal-title":"J Park Dis"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28533"},{"key":"e_1_3_3_44_2","first-page":"100126","article-title":"Change in the Parkinson anxiety scale correlates with change in other clinical measures of anxiety over time","volume":"6","author":"Schneider RB","year":"2022","unstructured":"Schneider RB, Auinger P, Tarolli CG, et al. Change in the Parkinson anxiety scale correlates with change in other clinical measures of anxiety over time. Clin Park Relat Disord 2022; 6: 100126.","journal-title":"Clin Park Relat Disord"},{"key":"e_1_3_3_45_2","article-title":"Alleviating stress in Parkinson\u2019s disease: symptomatic treatment, disease modification, or both?","volume":"14","author":"Goltz F","year":"2024","unstructured":"Goltz F, van der Heide A, Helmich RC. Alleviating stress in Parkinson\u2019s disease: symptomatic treatment, disease modification, or both? J Park Dis 2024; 14: S147\u2013S158.","journal-title":"J Park Dis"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2019.100191"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2019.10.015"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261463924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261463924","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261463924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:47:50Z","timestamp":1793947670000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261463924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/1877718X261463924"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261463924","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}